Rajen Mody MBBS

Associate Professor, Pediatrics
Specialties: 
Pediatric Hematology/Oncology, Pediatrics

Video profile

Locations

U of M Pediatrics Hematology/Oncology

Medical Professional Building D4207
1500 E Medical Center Dr SPC 5718
Ann Arbor
MI
48109
Phone:
734-764-7126
Fax:
734-615-0464

U of M Pediatric Hematology Oncology

C.S. Mott Children's Hospital, Level 7, Reception C
1540 E Hospital Dr., SPC 4257
Ann Arbor
MI
48109
Phone:
734-232-8700
Fax:
734-232-8740

Credentials

Medical School or Training

  • N.H.L Municipal Medical College, 1988

Residency

  • K.M. School Post Graduate Study and Research, Pediatrics, 1992

  • SUNY Health Science Center, Pediatrics, NY, 1997

Fellowship

  • Pediatric Oncology, Gujarat Cancer & Research Institute MP Shah Cancer Hospital, 1994

  • Pediatric Hematology/Oncology, University of Michigan Medical Center, 2000

Professional Organizations

  • American Society of Pediatric Hemtology-Oncology

  • American Association of Cancer Research

  • Children's Oncology Group

  • American Society of Hematology

Board Certification

  • Pediatric Hematology-Oncology

Research

Dr. Mody’s primary research interest is in development of new drugs against childhood cancers. He is the Principal Investigator of International Phase-II, randomized trial of Chimeric 14.18 or Temsirolimus in combination with Irinotecan/ Temozolomide by the Children’s Oncology Group (COG). He is also conducting a Phase-I trial of Bortezomib in combination with Irinotecan in refractory / relapsed neuroblastoma. He is a member of the High Risk Neurobalstoma Committee of COG and is the Principle Investigator of the Children's Oncology Group, Phase-I/ Phase II-III Consortium studies at C.S. Mott Children's Hospital.

Dr. Mody is also investigating role Precision Medicine in Pediatric Oncology through Next Generation Sequencing (NGS) in collaboration with the laboratory of Dr. Arul Chinnaiyan in the Michigan Center of Translational Pathology (MCTP).

Dr. Mody’s other interests include health related outcomes of childhood cancer survivors.

Biography

Dr. Rajen Mody joined the Division of Pediatric Hematology/Oncology following completion of his fellowship training in pediatric hematology/oncology at the University of Michigan. He subsequently completed his Masters in Science (MS) in clinical trials design and biostatistics at the school of public health at the university of Michigan. Before coming to Michigan, Dr. Mody completed a pediatric residency and chief residency at the State University of New York, in New York City. His research interests include new drug development against childhood cancers and role of precision medicine in pediatric oncology.